Aquestive Therapeutics, Inc.
Cash Flow Statement
| Line Item | FY2017 |
|---|---|
| Operating Activities | |
| Net Income | $-8.9M |
| Depreciation & Amortization | $3.8M |
| Depreciation | — |
| Amortization | $51.0K |
| Stock-Based Compensation | $0 |
| Net Cash from Operating Activities | $5.8M |
| Investing Activities | |
| Capital Expenditures | $2.1M |
| Business Acquisitions | — |
| Net Cash from Investing Activities | $-2.1M |
| Financing Activities | |
| Dividends Paid | — |
| Stock Repurchases | — |
| Net Cash from Financing Activities | $4.4M |
| Net Change in Cash | $8.2M |
| Free Cash Flow | $3.8M |